Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kyle Bass
Kyle Bass
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bloomberg
Mon, 04/10/17 - 10:06 am
Kyle Bass
patents
drug pricing
AMPYRA
Acorda Therapeutics
multiple sclerosis
Biogen Wins Tecfidera Patent Case
Investopedia
Wed, 03/22/17 - 10:02 am
Biogen
Tecfidera
patents
Kyle Bass
MS
multiple sclerosis
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Gilead Sciences
Biogen
patents
Merck
Kyle Bass
Amgen
Regeneron
Sanofi
Hedge fund manager Kyle Bass escapes sanctions in drug patent case
Yahoo/Reuters
Mon, 09/28/15 - 06:11 pm
Kyle Bass
patents
Celgene
Biotech CEO: Bass exploiting weakness in system
CNBC
Sun, 09/20/15 - 12:49 pm
Kyle Bass
patents
Acorda
Bass Vows to Keep Fighting U.S. Drug Patents After Setbacks
Bloomberg
Thu, 09/3/15 - 06:34 pm
Kyle Bass
patents
Biogen
Acorda Therapeutics
Biogen patent survives challenge by hedge fund manager Kyle Bass
Yahoo/Reuters
Wed, 09/2/15 - 05:14 pm
Kyle Bass
Biogen
patents
Acorda Therapeutics
Tecfidera
Hedge fund manager Kyle Bass loses first challenges to pharma patents
Yahoo/Reuters
Tue, 08/25/15 - 08:37 am
patents
AMPYRA
Kyle Bass
Acorda Therapeutics
MS
multiple sclerosis